Sponsor Pipeline

Suzhou BlueHorse Therapeutics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
1
Early Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07310784 A Phase II Trial of LM103 in Advanced Melanoma Advanced Melanoma Recruiting
NCT07444437 A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung… Non-Small Cell Lung Cancer Recruiting
Phase 1
NCT05366478 A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors Melanoma Recruiting
Early Phase 1
NCT06695689 An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced… Solid Tumor Recruiting
NCT06697665 An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and… Solid Cancer Recruiting
NCT05971576 A Clinical Study on TILs for the Treatment of Advanced Solid Tumors Solid Tumor Not Yet Recruiting
NCT05971589 A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors Solid Tumor Not Yet Recruiting
Disease Areas
Get alerts when Suzhou BlueHorse Therapeutics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free